Bbq Interview with CEO Anthony Tennyson3 Aug 2025 21:44
Https://audioboom.com/posts/8757812-the-sunday-bbq-featuring-anthony-tennyson-ceo-of-solvonis-therapeutics-plc-lse-svns-svns
SVN002 is 5 - 6 times the potential of Spravato, spravato selling over $1B P.A.
Worth a full listen, only 27 minutes long,crammed with investors info.
Reconfirmed fda like 002 and once the bridge to spravata data is ready they will file with FDA for svn002 phase 2 b trial.
Also they are running two tests on 002, 1. under the tongue and 2. against the cheek
Today and tomorrow London listing is their home, but would be remiss of him not to look for US listing in the medium term, to match their like for like competitors who are on X 10 - X 20 market caps.
Acknowledged high M&A activity for their type of pipeline and that they will look for licensing partners for 002.
Confirmed ptsd SVN014 will be focused on USA market and is very valuable, ptsd and the drugs to treat cocaine,and fentanyl.
Steered away from any low numbers or direct talk about current negotiations for SVN001.
That Dennis Purcell has the connections to get them listed on Nasdaq and is the deal maker.
Made a link between the fat jabs making Novo Nordisk the most valuable pharma in Europe at $600B top mkt cap and what their potential is with all of their pipeline, especially SVN014.
Very positive update, all on track!